Xin Lang Cai Jing·2026-01-13 01:17Group 1 - The core viewpoint of the news is that Junshi Biosciences experienced a decline in stock price while showing significant activity in financing and margin trading, indicating a high level of investor interest and potential volatility in the stock [1][2] Group 2 - On January 12, Junshi Biosciences' stock fell by 1.30%, with a trading volume of 5.09 billion yuan. The financing buy-in amount for the day was 60.41 million yuan, while the financing repayment was 44.22 million yuan, resulting in a net financing buy of 16.19 million yuan [1] - As of January 12, the total margin trading balance for Junshi Biosciences was 1.36 billion yuan, with the financing balance accounting for 4.54% of the circulating market value, which is above the 70th percentile level over the past year [1] - In terms of securities lending, on January 12, Junshi Biosciences had 6171 shares repaid and 800 shares sold short, with a short selling amount of 31,000 yuan. The remaining short selling volume was 388,300 shares, with a short selling balance of 15.02 million yuan, exceeding the 90th percentile level over the past year [1] Group 3 - Junshi Biosciences, established on December 27, 2012, focuses on the research and commercialization of monoclonal antibody drugs and other therapeutic protein drugs, with 90.67% of its revenue coming from drug sales [2] - As of September 30, the number of shareholders for Junshi Biosciences was 35,900, an increase of 15.17% from the previous period, while the average circulating shares per person decreased by 12.96% [2] - For the period from January to September 2025, Junshi Biosciences reported a revenue of 1.806 billion yuan, a year-on-year increase of 42.06%, while the net profit attributable to shareholders was -596 million yuan, a year-on-year increase of 35.72% [2] - As of September 30, 2025, the top ten circulating shareholders included E Fund's SSE STAR 50 ETF and Huaxia's SSE STAR 50 Component ETF, with both funds reducing their holdings compared to the previous period [2]